Influenza B Native Protein

• Reactivity: V-Vi
• Applications: ELISA
• Concentration: 1.75 mg/ml

Influenza B Native Protein Summary

• Description: Native influenza B antigen. Influenza B, strain Hong Kong 5/72, cultured in MDCK cells.
  
  

  Source:Virus

• Preparation Method: Clarified and concentrated cell culture supernatant. The antigen preparation is inactivated by gamma radiation.
• Protein/Peptide Type: Native Protein
• Purity: Concentrated Supernatant

Applications/Dilutions

• Dilutions:
  • ELISA
• Application Notes: Activity: 40960 HA units/ml as determined by hemagglutination endpoint assay.

Packaging, Storage & Formulations

• Storage: Store at -70C. Avoid freeze-thaw cycles.
• Buffer: Eagle's Minimum Essential Medium
• Preservative: No Preservative
• Concentration: 1.75 mg/ml
• Purity: Concentrated Supernatant

Alternate Names for Influenza B Native Protein

• Influenza B Virus NP; NP; Nucleoprotein

Background

Influenza A and B are the two types of influenza viruses that cause epidemic human disease. Influenza B viruses currently circulating are divided into two antigenically and genetically distinct groups: the Victoria and Yamagata lineages.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.